HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,405-1,416 of 1,979
Drug study icon
TerminatedNCT03643159

A study to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolarity type I, and Major Depressive Disorder

Official study title

A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

This study ended early.

Multiple locations, including Santa Rosa
Depression, Bipolarity, ...Medication studyAges 18–63
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Other study type icon
CompletedNCT03386851

Abilify Maintena PMS in Schizophrenia Patients or Bipolarity type I

Official study title

Post-Marketing Surveillance of Safety and Effectiveness of Abilify Maintena® Injections in Korean Patients With Schizophrenia or Bipolar 1 Disorder Under the "New Drug Re-Examination"

This study has finished and is no longer accepting participants.

In Gwangju
Bipolarity, SchizophreniaObservational studyAges 19+
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Other study type icon
CompletedNCT01028196

Observational Study to Evaluate Bipolarity Symptoms in Patients Presented With Schizophrenia or Depression

Official study title

Epidemiological Observational Non-interventional Study to Research the Prevalence of Bipolar Criteria of Hospital In-patients With Schizophrenia and Patients With Recurrent Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Chita
Bipolarity, Depression, ...Observational studyAges 18–65
Countries
Russia
Sponsor
AstraZeneca
Other study type icon
CompletedNCT02050854

Safety study of pharmacokinetics of Aripiprazole in schizophrenia

Official study title

An Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia Who Have a History of Suboptimal Adherence and Are Currently on Treatment With Oral Aripiprazole

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
Bipolarity, SchizophreniaObservational studyAges 18–55
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00001483

Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression

Official study title

Acute Efficacy of Bupropion, Sertraline, and Venlafaxine as Adjuvant Treatment to Mood Stabilizers in Bipolar Depression: A Randomized, Double-Blind, Comparative Study

This study has finished and is no longer accepting participants.

In Bethesda
Depression, BipolarityMedication study
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.